Portfolio company
Sentinal 4D
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence models and three-dimensional imaging platforms for drug discovery and personalised oncology therapeutics for pharmaceutical firms and clinicians.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Tessel Biosciences
The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.
Asylia Diagnostics
This company develops an artificial intelligence platform to identify biomarkers and drug targets for precision immunotherapy for pharmaceutical and diagnostic firms.
Known Medicine
This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.
Persona-Dx
The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
PreComb
This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.
Serinus Biosciences
This company develops an artificial intelligence platform to design cancer therapeutics and combination therapies for the pharmaceutical and precision medicine industries.
ScreenIn3D Limited
This company develops microfluidic lab-on-a-chip platforms for drug developers to test therapies on patient-derived three-dimensional tumour samples.
